EPITOPES OF THE MYCOBACTERIAL HEAT-SHOCK PROTEIN-65 FOR HUMAN T-CELLS COMPRISE DIFFERENT STRUCTURES

被引:10
作者
MUNK, ME
SHINNICK, TM
KAUFMANN, SHE
机构
[1] UNIV ULM, DEPT MED MICROBIOL & IMMUNOL, ALBERT EINSTEIN ALLEE 11, W-7900 ULM, GERMANY
[2] CTR DIS CONTROL, DIV BACTERIAL DIS, HANSENS DIS LAB, ATLANTA, GA 30333 USA
关键词
heat shock protein(s); hsp; major histocompatibility complex; MHC; PBMC; peripheral blood mononuclear cells; S.I; stimulation index;
D O I
10.1016/S0171-2985(11)80334-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T cell recognition of foreign antigens is a result of a ternary complex between T cell receptor, nominal peptide and major histocompatibility complex molecule. It has been proposed that the nominal peptide, which is presented by accessory cells to T cells, has a characteristic structure which can be predicted on the basis of physicochemical criteria. To further, study this aspect, we stimulated T cells from normal human blood donors with synthetic peptides (each of approximately 15 amino acids in length) from the heat shock protein 65 of Mycobacterium tuberculosis-M. bovis. We found that while the characterization of certain epitopes follows commonly used predictions, other epitopes cannot be predicted by known methods. © 1990, Gustav Fischer Verlag · Stuttgart · New York. All rights reserved.
引用
收藏
页码:272 / 277
页数:6
相关论文
共 23 条
[1]   T-CELL ANTIGENIC SITES TEND TO BE AMPHIPATHIC STRUCTURES [J].
DELISI, C ;
BERZOFSKY, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (20) :7048-7052
[2]   A COMPREHENSIVE SET OF SEQUENCE-ANALYSIS PROGRAMS FOR THE VAX [J].
DEVEREUX, J ;
HAEBERLI, P ;
SMITHIES, O .
NUCLEIC ACIDS RESEARCH, 1984, 12 (01) :387-395
[3]   A RECOMBINANT 64 KILODALTON PROTEIN OF MYCOBACTERIUM-BOVIS BACILLUS CALMETTE-GUERIN SPECIFICALLY STIMULATES HUMAN T4 CLONES REACTIVE TO MYCOBACTERIAL ANTIGENS [J].
EMMRICH, F ;
THOLE, J ;
VANEMBDEN, J ;
KAUFMANN, SHE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (04) :1024-1029
[4]  
FUJII Y, 1988, J IMMUNOL, V140, P1830
[5]  
GREAVES MF, 1974, J IMMUNOL, V112, P240
[6]  
HAHN H, 1981, REV INFECT DIS, V3, P1221
[7]  
HERBERKATZ E, 1983, J MOL CELL IMMUNOL, V1, P3
[8]  
HOUGHTEN RA, 1986, BIOTECHNIQUES, V4, P522
[9]  
HOUGHTEN RA, 1986, INT J PEPT PROT RES, V27, P673